<VariationArchive VariationID="1454636" VariationName="NM_153240.5(NPHP3):c.469del (p.Arg157fs)" VariationType="Deletion" Accession="VCV001454636" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1444975" VariationID="1454636">
      <GeneList>
        <Gene Symbol="NPHP3" FullName="nephrocystin 3" GeneID="27031" HGNC_ID="HGNC:7907" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132680609" stop="132722409" display_start="132680609" display_stop="132722409" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="132399452" stop="132441302" display_start="132399452" display_stop="132441302" Strand="-" />
          </Location>
          <OMIM>608002</OMIM>
        </Gene>
        <Gene Symbol="NPHP3-ACAD11" FullName="NPHP3-ACAD11 readthrough (NMD candidate)" GeneID="100532724" HGNC_ID="HGNC:48351" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132558138" stop="132722459" display_start="132558138" display_stop="132722459" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_153240.5(NPHP3):c.469del (p.Arg157fs)</Name>
      <CanonicalSPDI>NC_000003.12:132719754:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="132719755" stop="132719755" display_start="132719755" display_stop="132719755" variantLength="1" positionVCF="132719754" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="132438599" stop="132438599" display_start="132438599" display_stop="132438599" variantLength="1" positionVCF="132438598" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>R157fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.132438599del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.132438599del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.132719755del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.132719755del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008130.2" sequenceAccession="NG_008130" sequenceVersion="2" change="g.7678del">
            <Expression>NG_008130.2:g.7678del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_037804.1" sequenceAccession="NR_037804" sequenceVersion="1" change="n.573del">
            <Expression>NR_037804.1:n.573del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_153240.5" sequenceAccession="NM_153240" sequenceVersion="5" change="c.469del" MANESelect="true">
            <Expression>NM_153240.5:c.469del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_694972.3" sequenceAccession="NP_694972" sequenceVersion="3" change="p.Arg157fs">
            <Expression>NP_694972.3:p.Arg157fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="773760404" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_153240.5(NPHP3):c.469del (p.Arg157fs) AND Nephronophthisis" Accession="RCV001939549" Version="4">
        <ClassifiedConditionList TraitSetID="16865">
          <ClassifiedCondition DB="MedGen" ID="C0687120">Nephronophthisis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_153240.5(NPHP3):c.469del (p.Arg157fs) AND multiple conditions" Accession="RCV002497873" Version="1">
        <ClassifiedConditionList TraitSetID="10177">
          <ClassifiedCondition DB="MedGen" ID="C2673885">NPHP3-related Meckel-like syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1858392">Nephronophthisis 3</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3715199">Renal-hepatic-pancreatic dysplasia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-01-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_153240.5(NPHP3):c.469del (p.Arg157fs) AND NPHP3-related Meckel-like syndrome" Accession="RCV003485752" Version="1">
        <ClassifiedConditionList TraitSetID="677">
          <ClassifiedCondition DB="MedGen" ID="C2673885">NPHP3-related Meckel-like syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-06" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18371931</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23559409</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="16865" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">juvenile nephronophthisis</ElementValue>
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis</ElementValue>
                <XRef ID="72016" DB="GeneTests" />
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019005" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
                <XRef ID="204958008" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="206" />
                <XRef ID="206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C0687120" DB="MedGen" />
              <XRef ID="MONDO:0019005" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000090" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004748" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10177" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3602" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Renal-hepatic-pancreatic dysplasia 1</ElementValue>
                <XRef ID="MONDO:0008833" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RHPD1</ElementValue>
                <XRef Type="MIM" ID="208540" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18431" />
                <XRef ID="18431" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3715199" DB="MedGen" />
              <XRef ID="MONDO:0008833" DB="MONDO" />
              <XRef Type="MIM" ID="208540" DB="OMIM" />
            </Trait>
            <Trait ID="9804" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GOLDSTON SYNDROME</ElementValue>
                <XRef Type="MIM" ID="267010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Meckel syndrome type 7</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">NPHP3-related Meckel-like syndrome</ElementValue>
                <XRef ID="MONDO:0009966" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dandy-Walker cyst with renal-hepatic-pancreatic dysplasia</ElementValue>
                <XRef ID="Dandy-Walker+Cyst+with+Renal-Hepatic-Pancreatic+Dysplasia/2103" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NPHP3</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MKS7</ElementValue>
                <XRef Type="MIM" ID="267010" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4665" />
                <XRef ID="4665" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3032" DB="Orphanet" />
              <XRef ID="C2673885" DB="MedGen" />
              <XRef ID="MONDO:0009966" DB="MONDO" />
              <XRef Type="MIM" ID="267010" DB="OMIM" />
            </Trait>
            <Trait ID="5620" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis 3</ElementValue>
                <XRef ID="72010" DB="GeneTests" />
                <XRef ID="MONDO:0011456" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adolescent nephronophthisis</ElementValue>
                <XRef ID="Adolescent+nephronophthisis/7636" DB="Genetic Alliance" />
                <XRef ID="444749006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NPHP3</ElementValue>
                <XRef Type="MIM" ID="604387" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NPH3</ElementValue>
                <XRef Type="MIM" ID="604387" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-Løken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18179" />
                <XRef ID="18179" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C1858392" DB="MedGen" />
              <XRef ID="MONDO:0011456" DB="MONDO" />
              <XRef Type="MIM" ID="604387" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="677" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9804" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GOLDSTON SYNDROME</ElementValue>
                <XRef Type="MIM" ID="267010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Meckel syndrome type 7</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">NPHP3-related Meckel-like syndrome</ElementValue>
                <XRef ID="MONDO:0009966" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dandy-Walker cyst with renal-hepatic-pancreatic dysplasia</ElementValue>
                <XRef ID="Dandy-Walker+Cyst+with+Renal-Hepatic-Pancreatic+Dysplasia/2103" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">NPHP3</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MKS7</ElementValue>
                <XRef Type="MIM" ID="267010" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4665" />
                <XRef ID="4665" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3032" DB="Orphanet" />
              <XRef ID="C2673885" DB="MedGen" />
              <XRef ID="MONDO:0009966" DB="MONDO" />
              <XRef Type="MIM" ID="267010" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5458174" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_153240.5:c.469del|OMIM:208540;267010;604387" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002806398" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.5:c.469del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="208540" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="267010" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604387" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7915445" SubmissionDate="2024-01-28" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="NM_153240.5:c.469del|OMIM:267010" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004239067" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="Johns Hopkins Genomics, Johns Hopkins University" OrgID="506823" OrganizationCategory="laboratory" OrgAbbreviation="JHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This NPHP3 variant (rs773760404) is rare (&lt;0.1%) in a large population dataset (gnomAD v3.1.2: 3/151942 total alleles; 0.002%; no homozygotes). It has been reported in ClinVar (Variation ID 1454636), but has not been reported in the literature, to our knowledge. This frameshift variant results in a premature stop codon in exon 3 of 27, likely leading to nonsense-mediated decay and lack of protein production. We consider c.469del in NPHP3 to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_153240.5:c.469del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="267010" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14178466</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4253774" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="97879|MedGen:C0687120" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002233131" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18371931</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23559409</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with NPHP3-related conditions. This variant is present in population databases (rs773760404, gnomAD 0.03%). This sequence change creates a premature translational stop signal (p.Arg157Glufs*31) in the NPHP3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHP3 are known to be pathogenic (PMID: 18371931, 23559409).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NPHP3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.132438599del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0687120" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5458174" TraitType="Disease" MappingType="XRef" MappingValue="208540" MappingRef="OMIM">
        <MedGen CUI="C3715199" Name="Renal-hepatic-pancreatic dysplasia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4253774" TraitType="Disease" MappingType="XRef" MappingValue="C0687120" MappingRef="MedGen">
        <MedGen CUI="C0687120" Name="Nephronophthisis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5458174" TraitType="Disease" MappingType="XRef" MappingValue="267010" MappingRef="OMIM">
        <MedGen CUI="C2673885" Name="NPHP3-related Meckel-like syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5458174" TraitType="Disease" MappingType="XRef" MappingValue="604387" MappingRef="OMIM">
        <MedGen CUI="C1858392" Name="Nephronophthisis 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7915445" TraitType="Disease" MappingType="XRef" MappingValue="267010" MappingRef="OMIM">
        <MedGen CUI="C2673885" Name="NPHP3-related Meckel-like syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

